HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Stark Selected Research

BP 2-94

10/2000Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Stark Research Topics

Disease

3Nervous System Diseases (Neurological Disorders)
01/2017 - 09/2015
3Schizophrenia (Dementia Praecox)
01/2016 - 12/2001
3Neoplasms (Cancer)
11/2006 - 01/2000
2Parkinson Disease (Parkinson's Disease)
10/2019 - 06/2005
2Hypersensitivity (Allergy)
11/2014 - 07/2010
2Alzheimer Disease (Alzheimer's Disease)
03/2006 - 12/2001
1Myocarditis (Carditis)
12/2018
1Brain Diseases (Brain Disorder)
01/2016
1Hypokinesia (Bradykinesia)
12/2015
1Restless Legs Syndrome (Restless Legs)
09/2015
1Oral Lichen Planus
04/2015
1Thymoma (Thymic Carcinoma)
12/2014
1Dermatitis
11/2014
1Allergic Contact Dermatitis
11/2014
1Inflammation (Inflammations)
11/2014
1Hemorrhage
07/2014
1Carpal Tunnel Syndrome
10/2013
1Sialadenitis
08/2012
1Autoimmune Diseases (Autoimmune Disease)
08/2012
1Pruritus (Itching)
09/2011
1Skin Diseases (Skin Disease)
07/2010
1Immune System Diseases (Immune Disorders)
03/2010
1Cognitive Dysfunction
01/2007
1Memory Disorders (Memory Loss)
01/2007
1Hodgkin Disease (Hodgkin's Disease)
11/2006
1Dyskinesias (Dyskinesia)
06/2005
1Wounds and Injuries (Trauma)
04/2005
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2005
1Mental Disorders (Mental Disorder)
01/2003
1Cystitis
10/2000
1Edema (Dropsy)
10/2000
1AIDS-Related Complex (ARC)
04/2000

Drug/Important Bio-Agent (IBA)

8Histamine (Histamine Dihydrochloride)FDA Link
12/2018 - 12/2001
3Histamine Receptors (Histamine Receptor)IBA
12/2018 - 04/2005
2LigandsIBA
01/2017 - 01/2016
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2017 - 04/2005
2Dopamine (Intropin)FDA LinkGeneric
01/2016 - 12/2015
2Histamine H4 ReceptorsIBA
04/2015 - 09/2011
2Cetirizine (Zyrtec)FDA LinkGeneric
11/2014 - 09/2011
2pitolisantIBA
09/2011 - 01/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2006 - 10/2000
2Histamine H3 Receptors (Histamine H3 Receptor)IBA
03/2006 - 04/2005
2DNA (Deoxyribonucleic Acid)IBA
11/2000 - 01/2000
1rasagiline (Azilect)FDA Link
10/2019
1Monoamine Oxidase (MAO)IBA
10/2019
1Oxidoreductases (Dehydrogenase)IBA
01/2017
1Dopamine Agents (Dopaminergic Agents)IBA
01/2016
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2015
1Dopamine D3 ReceptorsIBA
09/2015
1CalciumIBA
12/2014
1Pyrilamine (Mepyramine)FDA Link
11/2014
1Olopatadine Hydrochloride (Patanol)FDA Link
11/2014
1CytokinesIBA
11/2014
1Histamine Antagonists (Antihistamines)IBA
11/2014
1Histamine H1 AntagonistsIBA
11/2014
1azelastine (Optivar)FDA LinkGeneric
11/2014
1Tuberculin (PPD)IBA
07/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2013
11- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
09/2011
1Ranitidine (Zantac)FDA LinkGeneric
09/2011
1Pharmaceutical PreparationsIBA
01/2007
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2006
1Procarbazine (Matulane)FDA Link
11/2006
1Vincristine (Oncovin)FDA LinkGeneric
11/2006
1Prednisone (Sone)FDA LinkGeneric
11/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2006
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2006
1Dopamine Receptors (Dopamine Receptor)IBA
06/2005
1Levodopa (L Dopa)FDA LinkGeneric
06/2005
1Messenger RNA (mRNA)IBA
04/2005
1Superoxide DismutaseIBA
04/2005
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2005
1Nootropic Agents (Nootropics)IBA
01/2003
1Liposomes (Liposome)IBA
11/2000
1BP 2-94IBA
10/2000
1CarrageenanIBA
10/2000
1Blood Proteins (Serum Proteins)IBA
10/2000
1VDR interacting protein complex DRIPIBA
04/2000
1dioleyldimethylammonium chlorideIBA
01/2000
1LipidsIBA
01/2000

Therapy/Procedure

3Therapeutics
01/2016 - 06/2005
1Antineoplastic Protocols
11/2006
1Oral Administration
10/2000